USNA
Income statement / Annual
Last year (2023), USANA Health Sciences, Inc.'s total revenue was $921.01 M,
a decrease of 7.77% from the previous year.
In 2023, USANA Health Sciences, Inc.'s net income was $63.79 M.
See USANA Health Sciences, Inc.�s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/30/2023 |
12/31/2022 |
01/01/2022 |
01/02/2021 |
12/28/2019 |
12/29/2018 |
12/30/2017 |
12/31/2016 |
01/02/2016 |
01/03/2015 |
| Operating Revenue |
$921.01 M
|
$998.60 M
|
$1.19 B
|
$1.13 B
|
$1.06 B
|
$1.19 B
|
$1.05 B
|
$1.01 B
|
$918.50 M
|
$790.47 M
|
| Cost of Revenue |
$176.69 M |
$193.89 M |
$217.90 M |
$209.11 M |
$187.50 M |
$200.71 M |
$179.40 M |
$180.19 M |
$159.68 M |
$140.79 M |
| Gross Profit |
$744.32 M |
$804.71 M |
$968.57 M |
$925.53 M |
$873.40 M |
$988.54 M |
$867.86 M |
$825.89 M |
$758.82 M |
$649.68 M |
| Gross Profit Ratio |
0.81 |
0.81 |
0.82 |
0.82 |
0.82 |
0.83 |
0.83 |
0.82 |
0.83 |
0.82 |
| Research and Development
Expenses |
$11.45 M
|
$11.56 M
|
$11.11 M
|
$10.63 M
|
$10.26 M
|
$10.24 M
|
$8.95 M
|
$8.84 M
|
$6.42 M
|
$5.13 M
|
| General & Administrative
Expenses |
$256.99 M
|
$262.30 M
|
$279.11 M
|
$261.19 M
|
$267.73 M
|
$275.06 M
|
$265.09 M
|
$234.19 M
|
$209.00 M
|
$184.53 M
|
| Selling & Marketing
Expenses |
$0.00
|
$434.79 M
|
$519.27 M
|
$487.86 M
|
$459.48 M
|
$525.13 M
|
$470.26 M
|
$453.08 M
|
$408.16 M
|
$349.04 M
|
| Selling, General &
Administrative Expenses |
$256.99 M
|
$697.10 M
|
$798.37 M
|
$749.04 M
|
$727.21 M
|
$800.19 M
|
$735.36 M
|
$687.27 M
|
$617.16 M
|
$533.58 M
|
| Other Expenses |
$382.81 M |
$1.01 M |
$450,000.00 |
$1.46 M |
$4.31 M |
$3.16 M |
$2.14 M |
-$70,000.00 |
$927,000.00 |
-$449,000.00 |
| Operating Expenses |
$651.25 M |
$697.10 M |
$798.37 M |
$749.04 M |
$727.21 M |
$800.19 M |
$735.36 M |
$687.27 M |
$617.16 M |
$533.58 M |
| Cost And Expenses |
$827.94 M |
$890.99 M |
$1.02 B |
$958.15 M |
$914.71 M |
$1.00 B |
$914.76 M |
$867.46 M |
$776.84 M |
$674.37 M |
| Interest Income |
$9.64 M |
$3.79 M |
$2.52 M |
$2.54 M |
$4.71 M |
$4.43 M |
$2.19 M |
$1.48 M |
$1.12 M |
$500,000.00 |
| Interest Expense |
$262,000.00 |
$192,000.00 |
$57,000.00 |
$507,000.00 |
$66,000.00 |
$36,000.00 |
$46,000.00 |
$444,000.00 |
$15,000.00 |
$129,000.00 |
| Depreciation &
Amortization |
$20.40 M
|
$21.41 M
|
$22.19 M
|
$22.51 M
|
$22.79 M
|
$16.73 M
|
$15.96 M
|
$13.48 M
|
$9.98 M
|
$8.81 M
|
| EBITDA |
$123.11 M
|
$130.22 M
|
$192.89 M
|
$200.96 M
|
$146.19 M
|
$188.35 M
|
$132.50 M
|
$152.10 M
|
$151.64 M
|
$124.91 M
|
| EBITDA Ratio |
0.13 |
0.11 |
0.14 |
0.16 |
0.14 |
0.16 |
0.13 |
0.14 |
0.15 |
0.15 |
| Operating Income Ratio
|
0.1
|
0.11
|
0.14
|
0.16
|
0.14
|
0.16
|
0.13
|
0.14
|
0.15
|
0.15
|
| Total Other
Income/Expenses Net |
$9.38 M
|
$1.01 M
|
$450,000.00
|
$1.46 M
|
$4.31 M
|
$3.16 M
|
$2.14 M
|
-$70,000.00
|
$927,000.00
|
-$449,000.00
|
| Income Before Tax |
$102.45 M |
$108.62 M |
$170.64 M |
$177.95 M |
$150.50 M |
$191.51 M |
$134.64 M |
$138.55 M |
$142.59 M |
$115.65 M |
| Income Before Tax Ratio
|
0.11
|
0.11
|
0.14
|
0.16
|
0.14
|
0.16
|
0.13
|
0.14
|
0.16
|
0.15
|
| Income Tax Expense |
$38.67 M |
$39.27 M |
$54.14 M |
$53.28 M |
$49.97 M |
$65.29 M |
$72.11 M |
$38.51 M |
$47.92 M |
$39.02 M |
| Net Income |
$63.79 M |
$69.35 M |
$116.51 M |
$124.66 M |
$100.53 M |
$126.22 M |
$62.54 M |
$100.04 M |
$94.67 M |
$76.64 M |
| Net Income Ratio |
0.07 |
0.07 |
0.1 |
0.11 |
0.09 |
0.11 |
0.06 |
0.1 |
0.1 |
0.1 |
| EPS |
3.31 |
3.6 |
5.78 |
5.89 |
4.44 |
5.36 |
2.6 |
4.09 |
3.71 |
3.11 |
| EPS Diluted |
3.3 |
3.59 |
5.73 |
5.86 |
4.41 |
5.12 |
2.53 |
3.99 |
3.59 |
2.8 |
| Weighted Average Shares
Out |
$19.25 M
|
$19.25 M
|
$20.15 M
|
$21.16 M
|
$22.64 M
|
$23.57 M
|
$24.02 M
|
$24.49 M
|
$24.98 M
|
$25.27 M
|
| Weighted Average Shares
Out Diluted |
$19.35 M
|
$19.31 M
|
$20.34 M
|
$21.26 M
|
$22.82 M
|
$24.64 M
|
$24.71 M
|
$25.05 M
|
$26.35 M
|
$27.38 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
